Laipson African Swine Fever Virus Indirect ELISA Antibody Test Kit obtains National New Veterinary D

2026.11.06

Recently, the Ministry of Agriculture and Rural Affairs issued Announcement No. 1080. In accordance with the provisions of the "Regulations on the Administration of Veterinary Drugs" the "Measures for the Registration of Veterinary Drugs", after strict review, the African Swine Fever Virus Indirect ELISA Antibody Test Kit declared by Luoyang Modern Biotechnology Research Institute Co Ltd., Luoyang Laipson Information Technology Co., Ltd., and others has been approved as a new national veterinary drug.

African swine fever is a highly virulent exotic disease threatening China's pig industry, characterized by a high mortality rate, hidden transmission, and strong virus survival capability. Once an occurs, it will cause devastating losses to pig farms and disrupt the circulation of live pigs.

The indirect ELISA antibody test kit for African swine fever virus approved this time provides a reliable tool for routine monitoring of pig herds and screening for subclinical infections, strengthening the first line of defense in pig disease prevention and control.


PREV:Wopson's Lumpy Skin Disease Vaccine (Inactivated, Strain NMG, Suspension Culture) has been officiall
NEXT:The Last